Addex Therapeutics ADXN 深 沪
已收盘 11-13 16:00:00 美东时间
4.06
-1.230
-23.25%
华盛通- 最 高5.00
- 今 开4.75
- 成交量 55.97万股
- 最 低 3.75
- 昨 收 5.29
- 总市值 711.49万
- 52周最高 10.43
- 市盈率 静 --
- 换手率 31.94%
- 52周最低 2.56
- 委 比 81.82%
- 总股本 175.24万
- 历史最高 750.40
- 量 比 0.10
- 振 幅 23.63%
- 历史最低 0.00
- 每 手 1
- 风险率 1.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Tetra Tech Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Tetra Tech Inc (NASDAQ:TTEK) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results. Tetra Tech reported quarterly earnings of 49 cents per share, which beat the analyst consensus estimate of 47 cents per share. The company repor...
11-12 17:56
Neurosterix Closes $105 Million Series B Financing
Addex Therapeutics ( ($CH:ADXN) ) has issued an announcement. Addex Therapeutic...
11-12 06:02
Addex Spin-Out Neurosterix Advances Schizophrenia Drug NTX-253 Into Phase 2
The latest announcement is out from Addex Therapeutics ( ($CH:ADXN) ). Addex Th...
10-08 13:33
Earnings Scheduled For September 28, 2026
Companies Reporting Before The Bell • Kandi Technologies Gr (NASDAQ:KNDI) is likely to report earnings for its first quarter. • Inventiva (NASDAQ:IVA) is expected to report quarterly loss at $0.20 per share on revenue of $10.00 million. • Addex Therapeutics (NASDAQ:ADXN) is likely to report earnings...
09-28 19:11
Addex Therapeutics reports 1H results
Addex Therapeutics press release (ADXN): 1H basic and diluted loss per share remained stable at CHF 0.03 per share for the six-month periods ended June 30, 2026 and 2025. Cash and cash equivalents dec...
09-28 15:46
Addex Therapeutics Q2 EPS $(1.52) Up From $(2.90) YoY, Sales $12.650K Down From $44.031K YoY
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.52) per share. This is a 47.59 percent increase over losses of $(2.90) per share from the same period last year. The company reported $12.650 thousand in sales this quarter. This is a 71.27 percent decrease over sales of $44.031 thous...
09-28 14:05
Addex Therapeutics shares are trading higher after the company announced it regained full global rights to all GABAB positive allosteric modulator assets discovered under its research collaboration with Indivior UK.
Addex Therapeutics shares are trading higher after the company announced it regained full global rights to all GABAB positive allosteric modulator assets discovered under its research collaboration with Indivior UK.
09-25 20:28
Addex Therapeutics raises $2.8M via ATM offering, extending runway to Q4 2027
Addex Therapeutics (ADXN) has raised $2.8M (CHF 2.2M) in gross proceeds through its At-the-Market (ATM) offering agreement with H.C. Wainwright & Co. The clinical-stage biopharmaceutical firm sold 437...
08-26 15:24
